| CARD ID | 2057 | |
| Type of strain | Transgenic. | |
| Strain name | C57BL/6-Tg(Alb-OCLN) | |
| Internal Code | C57BL/6.Tg(Alb-OCLN) | |
| Submitter | Miura Naoyuki | |
| Submitter affiliation or code | Hamamatsu University School of Medicine | |
| Stock Type | ||
| Material Transfer Conditions |
In the following cases, you do not need to be in contact.
|
|
| Production method | in-house breeding | |
| Origin (In-house) | Organization | Hamamatsu University School of Medicine |
| Organization code | ||
| Developer | Naoyuki Miura, M.D., Ph.D. | |
| Origin (From other organizations) | Organization | |
| Organization code | ||
| Developer | ||
| Year introduced | ||
| Introduced Generation | ||
| Remarks | ||
| Gene symbol | OCDN |
| Gene name | Occludin |
| Allele symbol | Tg(Alb-OCLN) |
| Allele name | transgene insertion |
| MGI | |
| Chromosome | Unknown , |
| Gene classification | Gene to express(transgenic) |
| Method | |
| OMIM |
| see the photograph page | |
| Author | Hikosaka K, Noritake H, Kimura W, Sultana S et al. |
| Title | Expression of human factors CD81, claudin-1, scavenger receptor, and occluding in mouse hepatocytes does not confer susceptibility to HCV entry. |
| Journal | Biomedical Research |
| Volume | 32 |
| Page | 143-150 |
| Year | 2011 |
| PMID |
| Disease name, Applicable field | Digestive Disorders |